[18F]Fluorocholine PET/CT as First-Line vs. Second-Line Imaging Method to localize parathyroid adenomas in primary hyperparathyroidism: “Game, Set, and Match” Giorgio TregliaArnoldo PiccardoAlessio Imperiale Editorial 29 May 2024
Rapid advancements in PET/MR: the 4th chinese PET/MR academic symposium Min ZhangRui GuoBiao Li Editorial 28 May 2024
Individual cerebellar metabolic connectome in patients with MTLE and NTLE associated with surgical prognosis Yongxiang TangHaoyue ZhuLi Feng Original Article 28 May 2024
Models using comprehensive, lesion-level, longitudinal [68Ga]Ga-DOTA-TATE PET-derived features lead to superior outcome prediction in neuroendocrine tumor patients treated with [177Lu]Lu-DOTA-TATE Victor Santoro-FernandesBrayden SchottRobert Jeraj Original Article 25 May 2024
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial Luca GuerraStephane Chauvieon behalf of Fondazione Italiana Linfomi (FIL) Original Article 25 May 2024
Correction to: Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy Tiancheng LiMimi XuXinhui Su Correction 24 May 2024
Why and how optical molecular imaging should further be catalyzed by nuclear medicine and molecular imaging: report from the EANM piloting group J. VonkR. A.J.O. DierckxS. Kruijff Editorial 24 May 2024
Patient communication of nuclear imaging results: do nuclear medicine practitioners have a role to play? Sandra GonzalezFrédéric ComteDavid Taïeb Editorial 24 May 2024
Development and evaluation of albumin binder-conjugated heterodimeric radiopharmaceuticals targeting integrin αvβ3 and CD13 for cancer therapy Biao YangChangyu ShanYongkang Gai Original Article 24 May 2024
PET imaging of Aspergillus infection using Zirconium-89 labeled anti-β-glucan antibody fragments Jianhao LaiSwati ShahDima A. Hammoud Original Article Open access 24 May 2024
Lutetium [177Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) study Secondo LastoriaMarcello RodariEttore Seregni Original Article Open access 22 May 2024
STING-targeted PET imaging: unveiling tumor immunogenicity post-chemotherapy in colorectal cancer Chao LiRachel J. SaladinWeiyu Chen Editorial 21 May 2024
Concomitant metastatic head-and-neck cancer and pancreatic cancer assessed by αvβ6-integrin PET/CT using 68Ga-Trivehexin: incidental detection of a brain metastasis Jana RehmRobert WinzerJörg Kotzerke Image of the Month Open access 21 May 2024
Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor Tao ZhangXinrui MaZibo Li Original Article 21 May 2024
Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma Daniela WeilerMaria del Sol Pérez Lago Image of the Month 20 May 2024
[68Ga]Ga-FAPI-04 PET/MR imaging strategy in management of Krukenberg tumors (KTs) from gastric signet-ring-cell carcinoma: to overcome limitation of [68Ga]Ga-FAPI-04 PET imaging in KTs Tingting WangGan HuangJianjun Liu Original Article 20 May 2024
Optimization and impact of sensitivity mode on abbreviated scan protocols with population-based input function for parametric imaging of [18F]-FDG for a long axial FOV PET scanner W. LanH. SariF. P. Schmidt Original Article Open access 20 May 2024
[68Ga]Ga-FAPI-46 PET/CT for penile cancer – a feasibility study Lennert EismannStephan T. LedderoseLena M. Unterrainer Short Communication 18 May 2024
Distinct [18F]FDG-PET imaging features of a newly recognized and yet uncharacterized RDD-ECD overlap disease entity Martin W. HuellnerMarco M. BühlerWiebke Rösler Image of the Month Open access 17 May 2024
Assessment of cerebral drug occupancy in humans using a single PET-scan: A [11C]UCB-J PET study Maja R. Marstrand-JoergensenGjertrud L. LaurellLars H. Pinborg Original Article Open access 17 May 2024
FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis Peter George MalihaMasatoshi HottaJeremie Calais Original Article 16 May 2024
Comment on: Is work overload associated with diagnostic errors on [18F]FDG PET/CT Guillaume HourcauDavid Taïeb Letter to the Editor 14 May 2024
Cholecystokinin-2 receptor targeting by [68Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer Gianpaolo Di SantoGiulia SantoIrene Virgolini Image of the Month Open access 14 May 2024
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer Sofia C. VazJohn Patrick Pilkington WollLioe-Fee de Geus-Oei Guidelines Open access 14 May 2024
The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future Elif Hindié Editorial 13 May 2024
Biological characterization of renal masses using immuno-PET Fabrizia GelardiAlessandro LarcherArturo Chiti Editorial 11 May 2024
CYP3A4 inhibitors may influence the quantification of [123I]I-FP-CIT SPECT scans Jan BooijEda YağciYoussef Chahid Short Communication Open access 11 May 2024
Seasonal variation in D2/3 dopamine receptor availability in the human brain Lihua SunTuulia MalénLauri Nummenmaa Original Article Open access 11 May 2024
Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4–1BB Zhipeng CaoChristian Werner WichmannAndrew Mark Scott Original Article Open access 11 May 2024
Coronary sodium [18F]fluoride activity predicts outcomes post-CABG: a comparative evaluation with conventional metrics Mingxin GaoWanwan WenXiang Li Original Article 11 May 2024
Diagnostic efficacy of [68Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [18F]F-FDG: results from a prospective clinical study Hui YuanEntao LiuLei Jiang Original Article 10 May 2024
A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study Jieling ZhengGuochang WangWeibing Miao Original Article 10 May 2024
The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study Yi FengBo ChengWenhua Liang Original Article Open access 09 May 2024
Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography Nourhan ShalabyYing XiaJohn A. Ronald Original Article Open access 09 May 2024
Total-body imaging of mu-opioid receptors with [11C]carfentanil in non-human primates Chia-Ju HsiehCatherine HouRobert H. Mach Original Article Open access 09 May 2024
Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranostics Song XueAndrei GafitaKuangyu Shi Original Article Open access 09 May 2024
Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles Stefan StanglNghia Trong NguyenJohannes Notni Original Article Open access 08 May 2024
Assessment of [18F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function Maria MeindlArtem ZatcepinMatthias Brendel Original Article Open access 08 May 2024
Collection on molecular imaging in cardiac amyloidosis Federico CaobelliChristoph Rischpler Editorial 07 May 2024
[18F]AlF-NOTA-PCP2: a novel PET/CT tracer for enhanced PD-L1 heterogeneity imaging and comparative analysis with [18F]AlF-NOTA-WL12 in glioblastoma xenografts Yong WangYang ZhangMan Hu Original Article 07 May 2024
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines David GroheuxSofia C. VazLioe-Fee de Geus-Oei Editorial 02 May 2024
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours Paola MapelliCarolina BezziMaria Picchio Original Article 02 May 2024
Comparison of discovery rates and prognostic utility of [68Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer—a cross-sectional study Kilian KlugeHolger EinspielerAlexander Haug Original Article Open access 02 May 2024
Multicenter PET image harmonization using generative adversarial networks David HaberlClemens P. SpielvogelLaszlo Papp Original Article Open access 02 May 2024
Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy Tiancheng LiMimi XuXinhui Su Original Article 01 May 2024
EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours Donatienne Van WeehaegheBruno LapauwElsmarieke Van De Giessen Editorial 30 April 2024
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation Miriam PepponiValentina BertiAlessio Imperiale Original Article 30 April 2024
Nuclear medicine practice for the assessment of cardiac sarcoidosis and amyloidosis. A survey endorsed by the EANM and EACVI. Irene GotuzzoRiemer H.J.A. SlartPaola A. Erba Editorial 29 April 2024
Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties Haodong HouYuan PanFeng Gao Original Article 29 April 2024
Validation of cardiac image-derived input functions for functional PET quantification Murray Bruce ReedPatricia Anna HandschuhAndreas Hahn Original Article Open access 27 April 2024
